Net Profit Margin
since 2005
Calculation
Edwards Lifesciences Corp., net profit margin, long-term trends, calculation
| Net profit margin | = | 100 | × | Net income1 | ÷ | Net sales1 | |
|---|---|---|---|---|---|---|---|
| Dec 31, 2021 | 28.73% | = | 100 | × | 1,503,100) | ÷ | 5,232,500) |
| Dec 31, 2020 | 18.77% | = | 100 | × | 823,400) | ÷ | 4,386,300) |
| Dec 31, 2019 | 24.08% | = | 100 | × | 1,046,900) | ÷ | 4,348,000) |
| Dec 31, 2018 | 19.40% | = | 100 | × | 722,200) | ÷ | 3,722,800) |
| Dec 31, 2017 | 16.99% | = | 100 | × | 583,600) | ÷ | 3,435,300) |
| Dec 31, 2016 | 19.22% | = | 100 | × | 569,500) | ÷ | 2,963,700) |
| Dec 31, 2015 | 19.85% | = | 100 | × | 494,900) | ÷ | 2,493,700) |
| Dec 31, 2014 | 34.92% | = | 100 | × | 811,100) | ÷ | 2,322,900) |
| Dec 31, 2013 | 19.15% | = | 100 | × | 391,700) | ÷ | 2,045,500) |
| Dec 31, 2012 | 15.43% | = | 100 | × | 293,200) | ÷ | 1,899,600) |
| Dec 31, 2011 | 14.10% | = | 100 | × | 236,700) | ÷ | 1,678,600) |
| Dec 31, 2010 | 15.07% | = | 100 | × | 218,000) | ÷ | 1,447,000) |
| Dec 31, 2009 | 17.34% | = | 100 | × | 229,100) | ÷ | 1,321,400) |
| Dec 31, 2008 | 10.41% | = | 100 | × | 128,900) | ÷ | 1,237,700) |
| Dec 31, 2007 | 10.36% | = | 100 | × | 113,000) | ÷ | 1,091,100) |
| Dec 31, 2006 | 12.58% | = | 100 | × | 130,500) | ÷ | 1,037,000) |
| Dec 31, 2005 | 7.95% | = | 100 | × | 79,300) | ÷ | 997,900) |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$ in thousands
The financial data reflects several key trends in the company's performance over the period from 2005 to 2021. Net sales demonstrate a consistent upward trajectory, increasing steadily from approximately $998 million in 2005 to over $5.2 billion in 2021. This indicates sustained revenue growth throughout the years.
Net income exhibits a general growth trend as well, albeit with some fluctuations. Starting at $79.3 million in 2005, net income rose gradually, with notable jumps in certain years. Significant increases are observed in 2009, reaching $229.1 million, and again in 2014 at $811.1 million, followed by a dip in 2015 and 2016, before rising sharply to $1.5 billion in 2021. These variations suggest periods of enhanced profitability possibly linked to operational improvements or market conditions.
The net profit margin percentage, which measures profitability relative to sales, follows a generally positive trend with some volatility. It begins at 7.95% in 2005, peaks at an exceptionally high 34.92% in 2014, then somewhat normalizes ranging between approximately 16% and 28% in the later years. The 2014 peak signifies an unusually high-profit efficiency during that year, while subsequent years maintain strong but more moderate margins, illustrating effective cost control and profitability management.
- Revenue Growth
- Net sales nearly quintupled over the period, indicating robust expansion in the company's market reach and/or product demand.
- Profitability Trends
- Net income growth aligns with sales increases but shows more variability, highlighting periods of either higher operational costs, investments, or one-time events impacting earnings.
- Profit Margin Fluctuations
- Profit margins vary significantly year-over-year, with a standout peak in 2014 suggesting an exceptional operational year. Overall margins remain strong, underscoring good profitability management despite fluctuations.
In summary, the data depicts a company that has progressively expanded its revenue base with improving profitability over the long term, despite some volatility in net income and profit margins. This suggests a resilient business model capable of sustaining growth and generating healthy returns on sales.
Comparison to Competitors
Edwards Lifesciences Corp., net profit margin, long-term trends, comparison to competitors
| Edwards Lifesciences Corp. | Abbott Laboratories | Elevance Health Inc. | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
|---|---|---|---|---|---|---|
| Dec 31, 2021 | 28.73% | 16.42% | 4.46% | 29.85% | 11.97% | 6.06% |
| Dec 31, 2020 | 18.77% | 12.99% | 3.78% | 24.33% | 16.56% | 6.03% |
| Dec 31, 2019 | 24.08% | 11.56% | 4.66% | 30.80% | 15.16% | 5.76% |
| Dec 31, 2018 | 19.40% | 7.74% | 4.11% | 30.29% | 10.36% | 5.33% |
| Dec 31, 2017 | 16.99% | 1.74% | 4.31% | 21.09% | 13.56% | 5.28% |
| Dec 31, 2016 | 19.22% | 6.71% | 2.93% | 27.21% | 12.27% | 3.81% |
| Dec 31, 2015 | 19.85% | 21.68% | 3.27% | 24.69% | 13.20% | 3.72% |
| Dec 31, 2014 | 34.92% | 11.28% | 3.52% | 19.65% | 18.02% | 4.33% |
| Dec 31, 2013 | 19.15% | 11.79% | 3.55% | 29.62% | 20.90% | 4.62% |
| Dec 31, 2012 | 15.43% | 14.95% | 4.37% | 30.14% | 22.35% | 5.03% |
| Dec 31, 2011 | 14.10% | 12.17% | 4.42% | 28.17% | 19.43% | 5.08% |
| Dec 31, 2010 | 15.07% | 13.15% | 4.99% | 27.02% | 19.59% | 4.95% |
| Dec 31, 2009 | 17.34% | 18.68% | 7.80% | 22.11% | 14.86% | 4.42% |
| Dec 31, 2008 | 10.41% | 16.53% | 4.04% | 23.35% | 16.51% | 3.70% |
| Dec 31, 2007 | 10.36% | 13.92% | 5.56% | 24.06% | 22.78% | 6.26% |
| Dec 31, 2006 | 12.58% | 7.64% | 5.52% | 19.33% | 22.55% | 5.89% |
| Dec 31, 2005 | 7.95% | 15.10% | 5.53% | 41.41% | 17.94% | 7.36% |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Health Care Equipment & Services)
Edwards Lifesciences Corp., net profit margin, long-term trends, comparison to sector (health care equipment & services)
| Edwards Lifesciences Corp. | Health Care Equipment & Services | |
|---|---|---|
| Dec 31, 2021 | 28.73% | 7.14% |
| Dec 31, 2020 | 18.77% | 6.82% |
| Dec 31, 2019 | 24.08% | 6.91% |
| Dec 31, 2018 | 19.40% | 5.87% |
| Dec 31, 2017 | 16.99% | 5.60% |
| Dec 31, 2016 | 19.22% | 4.73% |
| Dec 31, 2015 | 19.85% | 5.78% |
| Dec 31, 2014 | 34.92% | 5.76% |
| Dec 31, 2013 | 19.15% | 6.37% |
| Dec 31, 2012 | 15.43% | 8.05% |
| Dec 31, 2011 | 14.10% | 7.40% |
| Dec 31, 2010 | 15.07% | 7.67% |
| Dec 31, 2009 | 17.34% | 8.63% |
| Dec 31, 2008 | 10.41% | 6.88% |
| Dec 31, 2007 | 10.36% | 8.40% |
| Dec 31, 2006 | 12.58% | 7.20% |
| Dec 31, 2005 | 7.95% | 9.04% |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Edwards Lifesciences Corp., net profit margin, long-term trends, comparison to industry (health care)
| Edwards Lifesciences Corp. | Health Care | |
|---|---|---|
| Dec 31, 2021 | 28.73% | 15.24% |
| Dec 31, 2020 | 18.77% | 10.27% |
| Dec 31, 2019 | 24.08% | 14.56% |
| Dec 31, 2018 | 19.40% | 12.61% |
| Dec 31, 2017 | 16.99% | 9.26% |
| Dec 31, 2016 | 19.22% | 12.80% |
| Dec 31, 2015 | 19.85% | 13.94% |
| Dec 31, 2014 | 34.92% | 14.40% |
| Dec 31, 2013 | 19.15% | 15.04% |
| Dec 31, 2012 | 15.43% | 13.92% |
| Dec 31, 2011 | 14.10% | 12.06% |
| Dec 31, 2010 | 15.07% | 11.90% |
| Dec 31, 2009 | 17.34% | 17.77% |
| Dec 31, 2008 | 10.41% | 13.00% |
| Dec 31, 2007 | 10.36% | 12.52% |
| Dec 31, 2006 | 12.58% | 15.30% |
| Dec 31, 2005 | 7.95% | 14.61% |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).